Inhalation Sciences gets PreciseInhale order from Westchina-Frontier Pharma Tech Co. Ltd. (WCFP), a leading Chinese CRO.

Inhalation Sciences (ISAB) has received an order from the Chinese CRO Westchina-Frontier Pharma Tech Co,. Ltd.(WCFP) on a PreciseInhale system, including its modules for in vivo studies. The order value is initially approx. 1.2 MSEK.

Westchina-Frontier Pharma Tech Co,. Ltd.(WCFP) is a CRO (Contract Research Organisation) located in Chengdu, Sichuan. With PreciseInhale, WCFP is broadening their offer within Inhalation research studies. WCPF is Inhalation Sciences first customer in the Asian market.

ISAB CEO Lena Heffler: “We are proud and happy to see our technology take a first step into the Chinese market. It is also exciting to see a CRO that expand their capacity to include PreciseInhale.”

For more information about Inhalation Sciences please contact:

Lena Heffler, CEO 
Email: lena.heffler@inhalation.se
Phone: +46 (0)70 205 96 20

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments for research into inhalation. The company’s patented lab instrument, PreciseInhale®, enables researchers to characterize, with high precision, how aerosols and small particles impact our lungs, and so our health, when we breathe them in.

The information above was provided by Inhalation Sciences Sweden AB (publ) according to EU Market Abuse Regulations. The information was provided, through the above contact person, for publication on July 27, 2018.